Debanti Banerjee

An Immunohistochemistry Proved Extensive Inflammatory Myofibroblastic Tumour of Lung: Being Treated with Crizotinib

Satadru Biswas, Bidisha Bandyopadhyay, Hambir Chowdhury, Kuntal Ray, Debanti Banerjee, Ritam Joarder, Souvik Paul, Debapriya Mondal, Sukanta Chakraborty & Chhaya Roy · Journal of Cancer and Tumor International · 2018

Inflammatory Myofibroblastic Tumour (IMT) is a rare entity which constitutes 0.04–1.2% of all lung tumours. Though IMT was first described as an ‘Interesting Benign Lung Tumour’, recurrence, the discovery of cytogenetic aberrations, a clonal population of cells and oncogenic prot...